BioSpace News Archive

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will present at the annual J.P. Morgan Healthcare Conference taking place January 9-12, 2023.

Procaps Group, S.A., a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced the termination of its previously-reported definitive agreement to acquire Grupo Somar from the sellers under the SPA.

Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., president and chief executive officer, will present a corporate overview at the 41st Annual J.P. Morgan Healthcare Conference, on Thursday, January 12, 2023, at 11:15 a.m. PT.

ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC) today announced that Jacob M. Chacko, M.D., chief executive officer, will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 11:15 a.m. PT.

Quipt Home Medical Corp., a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is very pleased to announce that it has acquired Great Elm Healthcare, LLC, a division of Great Elm Group, Inc., with an effective date of December 31, 2022.

Syneos Health®, the only fully integrated biopharmaceutical solutions organization, announced that Chief Executive Officer Michelle Keefe is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 10:30 a.m. EST.

Teva Pharmaceutical Industries Ltd. announced that members of management will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023.

AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the First Quarter of Fiscal 2023 on Wednesday, February 1, 2023, prior to the opening of trading on the New York Stock Exchange.

IVERIC bio, Inc. (Nasdaq: ISEE) announced today the election of Pravin U. Dugel, MD, President of Iveric Bio, to its Board of Directors, effective as of January 1, 2023.

RAPT Therapeutics, Inc. announced that Brian Wong, M.D., Ph.D., President and Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at 3:00 p.m. Pacific Time.